Researchers from Pennsylvania State University have developed a "GPS nanoparticle" that, after being injected intravenously, can home in on cancer cells to deliver a genetic punch to the protein implicated in tumor growth and spread. The researchers showed that this nanoparticle works for basal-like breast cancers, which are characterized by aggressive, quickly growing tumors that shed cancer cells, which then spread elsewhere in the body.
An official website of the United States government.